报价延迟最少15分钟:2026/04/03 21:17 EDT
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
4.32 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-0.06/0.02
|
|
企业价值
200.76M
|
| 资产负债 |
|
每股账面净值
0.37
|
| 现金流量 |
|
现金流量率
0.00
|
| 损益表 |
|
收益
41.13M
|
|
每股收益
0.64
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比较之报价最少15分钟延迟 (夜盘时段除外)
|
业务概览
|
|||
| KORU Medical Systems Inc develops, manufactures, and commercializes large volume subcutaneous infusion solutions for the subcutaneous drug delivery market. Its product portfolio focuses on mechanical infusion devices, including the FREEDOM60 and FreedomEdge syringe drivers, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company operates as one segment. Its revenue streams are: Domestic Core, International Core and Pharma services and clinical trials. The majority of the company's revenue is derived from the Domestic Core business, which consists of sales of its syringe drivers, tubing and needles. Geographically, its revenues are predominantly derived from the United States. |
